References
- Allen, B., & Harocopos, A. (2016). Non-prescribed buprenorphine in New York City: Motivations for use, practices of diversion, and experiences of stigma. Journal of Substance Abuse Treatment, 70, 81–86. https://doi.org/https://doi.org/10.1016/j.jsat.2016.08.002
- American College of Medical Toxicology, & American Academy of Clinical Toxicology. (2017). ACMT and AACT position statement: Preventing occupational fentanyl and fentanyl analog exposure to emergency responders.
- Atkins, J., Dopp, A. L., & Temaner, E. B. (2020). Combatting the stigma of addiction—The need for a comprehensive health system approach. NAM Perspectives. https://doi.org/https://doi.org/10.31478/202011d
- Ayoo, K., Mikhaeil, J., Huang, A., & Wąsowicz, M. (2020). The opioid crisis in North America: Facts and future lessons for Europe. Anaesthesiology Intensive Therapy, 52(2), 139–147. https://doi.org/https://doi.org/10.5114/ait.2020.94756
- Baumgartner, J., & Radley, D. (2021, August). The drug overdose toll in 2020 and near-term actions for addressing it. Commonwealth Fund. https://doi.org/https://doi.org/10.26099/gb4y-r129
- Beletsky, L., Seymour, S., Kang, S., Siegel, Z., Sinha, M. S., Marino, R., Dave, A., & Freifeld, C. (2020). Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media. The International Journal on Drug Policy, 86, 102951. https://doi.org/https://doi.org/10.1016/j.drugpo.2020.102951
- Bohnert, A. S. B., Guy, G. P., & Losby, J. L. (2018). Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention’s 2016 opioid guideline. Annals of Internal Medicine, 169(6), 367–375. https://doi.org/https://doi.org/10.7326/M18-1243
- Bozinoff, N., Anderson, B. J., Bailey, G. L., & Stein, M. D. (2018). Correlates of stigma severity among persons seeking opioid detoxification. Journal of Addiction Medicine, 12(1), 19–23. https://doi.org/https://doi.org/10.1097/ADM.0000000000000355
- Chancellor, S., Nitzburg, G., Hu, A., Zampieri, F., & De Choudhury, M. (2019). Discovering alternative treatments for opioid use recovery using social media. In Proceedings of the 2019 CHI Conference on Human Factors in Computing Systems (pp. 1–15). https://doi.org/https://doi.org/10.1145/3290605.3300354
- Cioe, K., Biondi, B. E., Easly, R., Simard, A., Zheng, X., & Springer, S. A. (2020). A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. Journal of Substance Abuse Treatment, 119, 108146. https://doi.org/https://doi.org/10.1016/j.jsat.2020.108146
- Evans, W., Andrade, E., Pratt, M., Mottern, A., Chavez, S., Calzetta-Raymond, A., & Gu, J. (2020). Peer-to-peer social media as an effective prevention strategy: Quasi-experimental evaluation. JMIR mHealth and uHealth, 8(5), e16207. https://doi.org/https://doi.org/10.2196/16207
- Garett, R., Yang, J., Zhang, Q., & Young, S. D. (2022). An online advertising intervention to increase adherence to Stay-at-Home-Orders during the COVID-19 pandemic: An efficacy trial monitoring individual-level mobility data. International Journal of Applied Earth Observation and Geoinformation, 108, 102752, ISSN 1569-8432. https://doi.org/https://doi.org/10.1016/j.jag.2022.102752.
- Garett, R., & Young, S. D. (2021). Online misinformation and vaccine hesitancy. Translational Behavioral Medicine, 11(12), 2194–2199. https://doi.org/https://doi.org/10.1093/tbm/ibab128
- Garett, R., & Young, S. D. (2022). The importance of diverse key stakeholders in deciding the role of artificial intelligence for HIV research and policy. Health Policy and Technology.
- Johnson, K. F., Worth, A., & Brookover, D. (2019). Families facing the opioid crisis: Content and frame analysis of YouTube videos. The Family Journal, 27(2), 209–220. https://doi.org/https://doi.org/10.1177/1066480719832507
- Kernan, W. D., Basch, C. H., Segall, L. E., & Garcia, P. (2020). A review of YouTube videos about the opioid antagonist medication naloxone. Journal of Consumer Health on the Internet, 24(2), 135–146. https://doi.org/https://doi.org/10.1080/15398285.2020.1752079
- Mahon, L. R., Hawthorne, A. N., Lee, J., Blue, H., & Palombi, L. (2018). Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: Illuminating barriers to pharmacist-led harm reduction. Harm Reduction Journal, 15(1), 57. https://doi.org/https://doi.org/10.1186/s12954-018-0262-6
- Moses, T. E., Chammaa, M., Ramos, R., Waineo, E., & Greenwald, M. K. (2020). Incoming medical students’ knowledge of and attitudes toward people with substance use disorders: Implications for curricular training. Substance Abuse, 42(4), 692–698. https://doi.org/https://doi.org/10.1080/08897077.2020.1843104
- National Cancer Institute. (2019). Health information national trends Survey 5 Cycle 3. National Cancer Institute. https://hints.cancer.gov/view-questions-topics/question-details.aspx?PK_Cycle=11&qid=688
- Nokes, K. M., Reyes, D. M., & Hickey, D. E. (2018). Perceptions of low income HIV + persons about finding accurate web-based health information. Applied Nursing Research: ANR, 42, 70–76. https://doi.org/https://doi.org/10.1016/j.apnr.2018.06.002
- Owens, B. (2019). Opioid prescriptions down but some patients fear doctors now too strict. CMAJ: Canadian Medical Association Journal = Journal de L’Association Medicale Canadienne, 191(19), E546–E547. https://doi.org/https://doi.org/10.1503/cmaj.109-5748
- Park, A., & Conway, M. (2018). Opioid surveillance using social media: How URLs are shared among Reddit members. International Society for Disease Surveillance. https://doi.org/https://doi.org/10.5210/ojphi.v10i1.8419
- Scorsone, K. L., Haozous, E. A., Hayes, L., & Cox, K. J. (2020). Overcoming barriers: Individual experiences obtaining medication-assisted treatment for opioid use disorder. Qualitative Health Research, 30(13), 2103–2117. https://doi.org/https://doi.org/10.1177/1049732320938689
- Sharma, A., Kelly, S. M., Mitchell, S. G., Gryczynski, J., O’Grady, K. E., & Schwartz, R. P. (2017). Update on barriers to pharmacotherapy for opioid use disorders. Current Psychiatry Reports, 19(6), 35. https://doi.org/https://doi.org/10.1007/s11920-017-0783-9
- Sokolow, A. (2020, July 16). States slash addiction treatment budgets, even as overdoses spike. STAT. https://www.statnews.com/2020/07/16/opioid-overdoses-have-skyrocketed-amid-the-coronavirus-but-states-are-nevertheless-slashing-addiction-treatment-program-budgets/
- Suffoletto, B., Lynch, M., Pacella, C. B., Yealy, D. M., & Callaway, C. W. (2018). The effect of a statewide mandatory prescription drug monitoring program on opioid prescribing by emergency medicine providers across 15 hospitals in a single health system. The Journal of Pain, 19(4), 430–438. https://doi.org/https://doi.org/10.1016/j.jpain.2017.11.010
- Swire-Thompson, B., & Lazer, D. (2020). Public health and online misinformation: Challenges and recommendations. Annual Review of Public Health, 41(1), 433–451. https://doi.org/https://doi.org/10.1146/annurev-publhealth-040119-094127
- Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019). Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Medicine, 16(11), e1002969. https://doi.org/https://doi.org/10.1371/journal.pmed.1002969
- van Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131(1–2), 23–35. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2013.02.018
- Velasquez M, Flannery M, Badolato R, et al. (2019). Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addict Sci Clin Pract, 14(1), 37. doi:https://doi.org/10.1186/s13722-019-0166-0.
- Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain—Misconceptions and mitigation strategies. The New England Journal of Medicine, 374(13), 1253–1263. https://doi.org/https://doi.org/10.1056/NEJMra1507771
- Wang, Y., McKee, M., Torbica, A., & Stuckler, D. (2019). Systematic literature review on the spread of health-related misinformation on social media. Social Science & Medicine (1982), 240, 112552. https://doi.org/https://doi.org/10.1016/j.socscimed.2019.112552
- Winograd, R. P., Phillips, S., Wood, C. A., Green, L., Costerison, B., Goulka, J., & Beletsky, L. (2020). Training to reduce emergency responders’ perceived overdose risk from contact with fentanyl: Early evidence of success. Harm Reduction Journal, 17(1), 58. https://doi.org/https://doi.org/10.1186/s12954-020-00402-2
- Young, S. D., & Heinzerling, K. (2017). The Harnessing Online Peer Education (HOPE) intervention for reducing prescription drug abuse: A qualitative study. Journal of Substance Use, 22(6), 592–596. https://doi.org/https://doi.org/10.1080/14659891.2016.1271039
- Young, S. D., Koussa, M., Lee, S.-J., Perez, H., Gill, N., Gelberg, L., & Heinzerling, K. (2018). Feasibility of a social media/online community support group intervention among chronic pain patients on opioid therapy. Journal of Addictive Diseases, 37(1–2), 96–101. https://doi.org/https://doi.org/10.1080/10550887.2018.1557992
- Young, S. D., Lee, S.-J., Perez, H., Gill, N., Gelberg, L., & Heinzerling, K. (2020). Social media as an emerging tool for reducing prescription opioid misuse risk factors. Heliyon, 6(3), e03471. https://doi.org/https://doi.org/10.1016/j.heliyon.2020.e03471